Delivery Order SPE2DB25D3017-SPE2DB25FVKQA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $3,247.94. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $3,232.63 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This competitively awarded contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units) with a contract ceiling value of $1,501.57. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,052.07. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units) with a contract ceiling value of $2,237.57. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by September 22, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a contract value of $6,506.97 and an ultimate completion date of July 31, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,919.88 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procedures. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a ceiling value of $2,094.39. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count) valued at $2,354.12. This competitive award, issued with firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's corporate office location...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKQADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count) under a firm fixed-price contract valued at $3,266.24. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a non-competitive delivery order without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order exemplifies the company's role as a critical pharmaceutical vendor to the Defense Health Agency and other federal healthcare systems, delivering medications across multiple therapeutic domains to meet operational medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/11/25 |